Can You Take GLP-1 If You Have Hypothyroidism? (October 2026)

01 · The core answer

Hypothyroidism and GLP-1 treatment: what applies to you

The thyroid warning on tirzepatide is about a specific cancer, not an underactive thyroid. In rodent studies tirzepatide caused thyroid C-cell tumours; it is not known whether this applies to humans, and no increase has been shown in human trials.¹ As a precaution, tell your prescriber if you or a close relative have had medullary thyroid cancer or the inherited condition MEN 2.¹³

Hypothyroidism, including the autoimmune form often called Hashimoto's, does not appear in the list of conditions that rule treatment out. Mounjaro should not be used if you are allergic to tirzepatide or any of its ingredients, or during pregnancy or while trying to conceive. Extra care applies with a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy or gallbladder problems.¹

That does not mean your thyroid condition is irrelevant. It means the decision belongs to a prescriber who has your whole picture. Our consultation is free, and if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.

02 · What to decide

The two decisions you are actually facing

The first decision is whether anything in your history is a genuine caution. The second is how your thyroid care and your weight-management care will work side by side.

If you are ready to be assessed, you can start a consultation for the Mounjaro pen. For wider context, our weight loss clinic hub explains the full treatment pathway.

If you want the Mounjaro-specific version of this question, see our guide on whether you can use Mounjaro with hypothyroidism.

The safest route is to declare everything, let the prescriber decide, and keep your thyroid team informed.

Related guide: Can i take mounjaro if i have hypothyroidism.

03 · The thyroid warning explained

What the thyroid warning on GLP-1 medicines actually means

The thyroid warning is about C-cell tumours seen in rodents, not about thyroid hormone levels. In rodent studies tirzepatide caused thyroid C-cell tumours; it is not known whether this applies to humans, and no increase has been shown in human trials.¹

This matters because people with hypothyroidism often read the word thyroid and assume the warning applies to them. The warning concerns a particular cancer type, medullary thyroid cancer, and an inherited condition, MEN 2. Neither is the same thing as an underactive thyroid, which is usually a question of how much hormone the gland makes.

The precaution is deliberately worded as a conversation, not a ban. Tell your prescriber if you or a close relative have had medullary thyroid cancer or the inherited condition MEN 2, and they will weigh this in your assessment.¹³ Weighing it means your prescriber looks at the whole picture and decides what is appropriate for you.

Why family history is on the form

MEN 2 is inherited, so your relatives' history can matter even if you have never had a thyroid problem yourself. If a close relative has had medullary thyroid cancer, mention it, even if the details are vague. Your prescriber would rather have an incomplete answer than none at all.

If you are not sure of your family history, say so. A prescriber can then decide whether to ask further questions or advise you to check with relatives or your GP first.

Routine monitoring

Routine thyroid monitoring is not required for most people on Mounjaro.¹³ That statement is about monitoring for the cancer concern. It does not replace whatever blood tests your GP or specialist already arranges for your underactive thyroid, and you should keep those appointments.

Equally, it does not tell us how your own thyroid medicine should be handled as your weight changes. Your GP or endocrinology team are the right people, and your prescriber should know you are taking thyroid medicine.

What to do if you are unsure

If you cannot tell whether your thyroid history involves cancer or an inherited condition, check your hospital letters or ask your GP before you order. If the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Our hypothyroidism-specific Mounjaro guide covers the same ground from a Mounjaro angle.

04 · How GLP-1 medicines work

How tirzepatide works, and why it is relevant to other medicines you take

Tirzepatide activates two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹ In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.

This dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy and Ozempic). Mounjaro is a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes.¹

Slower stomach emptying and your tablets

Because the medicine slows how quickly the stomach empties, readers sometimes ask whether tablets taken by mouth could be affected. For oral contraceptives the product information does say absorption can be reduced for this reason, and the MHRA has issued guidance.⁷ The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹

Put every medicine on your list at consultation, thyroid tablets included. Your prescriber can then decide whether anything needs attention, and your GP can advise on the timing and monitoring of your thyroid treatment.

What the mechanism does not tell you

The mechanism describes appetite, stomach emptying and insulin response. It is licensed for weight management and type 2 diabetes, not thyroid disease.

How long it stays in your system

If you stop, tirzepatide takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹

Treatment is used alongside a reduced-calorie diet and increased physical activity, not instead of them.

05 · Who should not take it

Who should not take Mounjaro, and where hypothyroidism fits

Mounjaro is not suitable for everyone, and the exclusions are specific. You should not take it if you are allergic to tirzepatide or any of its ingredients, and it should not be used during pregnancy or while trying to conceive.¹ Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly. These are the firm lines.

Your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy, or gallbladder problems.¹³ Hypothyroidism is not named in that list.

Why "who cannot take GLP-1 for thyroid reasons" has a narrow answer

The honest answer is that the thyroid-related caution applies to those with a personal or close family history of medullary thyroid cancer or MEN 2, and the prescriber weighs it. An underactive thyroid is a different matter and does not feature in the exclusions.

Having an additional condition from the extra-care list changes the picture, though. Someone with hypothyroidism and gallbladder problems, for example, has a gallbladder question that needs separate attention. Our guides on GLP-1 treatment with gallstones and on GLP-1 treatment with fatty liver cover those overlaps.

Other conditions that often travel with thyroid problems

Digestive complaints are common in people managing long-term conditions. If you have gastritis or other stomach problems, see our page on Mounjaro and gastritis. If you take medicines that can lower blood sugar, the relevant page is Mounjaro and low blood sugar.

Share everything

Always share your full medical history and medicine list during consultation.¹³ A thyroid condition is relevant detail even when it is not an exclusion. A good consultation is one where nothing was left out because you assumed it did not matter.

06 · What the trial evidence covers

What the trial evidence tells you, and what it does not

In SURMOUNT-1, of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.²

These are trial averages, and individual results vary. Treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them. At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight. Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.²

A worked example, with the limits stated

For someone starting at 100 kg, 20.9% is about 21 kg. That is straight arithmetic on a trial average, not a forecast for you.

Beyond the scales

In trials, weight loss on tirzepatide came with average improvements in waist size, blood pressure, cholesterol and blood-sugar measures, and most participants with prediabetes returned to normal blood-sugar levels.² These are trial-average secondary outcomes, not promises. They are why prescribers talk about weight management as health management rather than appearance.

Reading online claims carefully

You may find pages claiming that thyroid patients lose more or less on GLP-1 medicines, often with very specific numbers. A claim you cannot trace to a trial name and a source is not evidence.

If a particular result matters to your decision, ask your prescriber what the licensed information says about your circumstances. That conversation will be more useful than a figure from a forum thread or a social-media post.

07 · Weight, thyroid and honesty

Hypothyroidism and weight

What a GLP-1 medicine is for

Mounjaro is licensed for weight management in adults and for type 2 diabetes.¹ It is not a thyroid treatment. If your weight has changed because your thyroid was under-treated, the first step is usually a conversation with the clinician who manages your thyroid, not a new medicine.

Who is eligible for a weight-management prescription

Eligibility thresholds are based on BMI. Our consultation uses the licensed criteria, and your prescriber decides on suitability, with BMI thresholds of 27, 30, 35 and 40 kg/m² appearing in different contexts.

Practical steps that cost nothing

• Keep your regular thyroid blood tests and appointments.
• Write down your thyroid medicine name and the way you take it, so you can tell the prescriber accurately.
• Note any family history of thyroid cancer or MEN 2.
• Ask your GP whether anything should be reviewed if your weight changes substantially.

08 · Other GLP-1 options

Wegovy, other GLP-1 medicines and "which is safest for the thyroid"

Wegovy (semaglutide) is a once-weekly pen with a dose ladder of 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg. If you are asking whether you can use Wegovy with hypothyroidism, read its product information and ask the prescriber who would supply it.

Daily versus weekly injections

Liraglutide (sold as Saxenda, and in products such as Erly) is supplied at 6mg/ml and is a daily injection, unlike once-weekly Mounjaro and Wegovy.

How tirzepatide differs

Tirzepatide acts on two receptors, GIP and GLP-1, while semaglutide is single-action.¹ A mechanism difference does not, on its own, tell you which suits your thyroid history. That is a prescriber's judgement.

Choosing between them

The sensible approach is to let your prescriber consider your full history and then discuss options. If you want to explore a Wegovy order, see the Wegovy pen page for current pricing and consultation.

Avoid supplement shortcuts

Low-cost supplements marketed as natural alternatives carry dramatic weight-loss claims and offer no clinical oversight. They are not equivalent to licensed medicines, and dosing is not standardised. If you take thyroid tablets, adding unregulated products without telling your clinician is a poor idea.

Likewise, be wary of anyone offering to supply a prescription injection without a consultation or prescription. Counterfeit medicines are a real risk, and the MHRA publishes alerts and runs the Yellow Card scheme.⁷

09 · NHS and private access

NHS and private routes to GLP-1 treatment

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

Starting with your GP

If you have hypothyroidism, your GP already knows your thyroid history. That makes them a sensible first conversation, particularly if you want to check whether you fall within the phased NHS groups. Ask them too about any thyroid review they would want during weight change.

The private route, step by step

Ordering with us follows a simple journey.

• Complete a free online consultation, a short health questionnaire with no charge and no obligation.
• A GPhC-registered prescriber reviews it, rather than a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.
• Our registered pharmacy dispenses it, with same-day dispatch when ordered by 3pm, and free next-day tracked delivery in temperature-controlled packaging. Saturday delivery is £14.99.

Needles, a sharps bin and injection guidance come with every order. Repeat orders re-check suitability, and there is no auto-shipping.

Aftercare

Ongoing monthly reviews, dose titration and follow-up assessments are carried out by the prescribing team, with side-effect support. Support runs Monday to Friday, and you can reach us at support@everydaymeds.co.uk or on 0333 207 0413. We are GPhC-registered, number 9012878.

10 · Safety and monitoring

Side effects, kidneys, mood and what to report

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for severe, persistent stomach pain that may spread to your back, with or without vomiting, which could be pancreatitis.¹³ Also get medical help straight away for pain in the upper right abdomen, fever or yellowing of skin or eyes, which could indicate gallbladder problems, or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing.

Thyroid-specific symptoms

The label's thyroid precaution does not translate into a symptom checklist, and routine thyroid monitoring is not required for most people.¹³ If you notice anything new or worrying, including changes you suspect relate to your thyroid, tell your prescriber and your GP.

Kidneys and liver

Mounjaro is not known to damage kidneys or liver directly, and no dose adjustment is needed for mild to moderate kidney or liver impairment. The practical risk is indirect: severe vomiting or diarrhoea can cause dehydration, which can strain the kidneys, so keep fluids up and contact your clinical team if you cannot keep fluids down.¹ People with severe impairment need individual prescriber assessment.

Mood and mental health

The EMA's safety committee reviewed the evidence and concluded in 2024 that it does not support a causal link between GLP-1 medicines and low mood or suicidal thoughts, and the MHRA keeps this under continuous review.¹⁷ Even so, any big change in weight, appetite and routine can affect how you feel. Tell your prescriber about any history of depression, and seek help promptly if your mood drops or you have distressing thoughts.

If you have thoughts of harming yourself or ending your life, get help straight away. Call 999 or go to A&E if you are in immediate danger. In England you can call NHS 111 and choose the mental health option, any time. You can also call Samaritans free on 116 123, day or night. Tell your prescriber about any change in your mood while taking Mounjaro.

If you take insulin or a sulfonylurea

If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar, such as shakiness, sweating and confusion. Your prescriber may need to adjust those medicines.¹³

Storage basics

Unopened pens are stored in the fridge at 2–8°C until first use and keep until the printed expiry date. Once in use, a KwikPen can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use, and must then be thrown away. Follow the pen's instructions for each injection.